The effects of helicobacter pylori eradication on body mass index and dyspeptic symptoms

Digestion

Volumn 79, Issue 4, 2009, Pages 235-242

  Suto, Hiroyuki ^a   Yamazaki, Yukinao ^a   Yoshida, Ikumi ^a   Yamakawa, Akiyo ^a   Ohtani, Masahiro ^a   Ito, Yoshiyuki ^a   Kuriyama, Masaru ^a   Kato, Takuji ^b   Azuma, Takeshi ^c  

^a UNIVERSITY OF FUKUI   (Japan)

^b FUKUI PREFECTURAL UNIVERSITY   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Body mass index; Dyspepsia; Helicobacter pylori eradication; Pepsinogen I II ratio

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; PEPSINOGEN I; PEPSINOGEN II;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; ATROPHIC GASTRITIS; BODY MASS; CONTROLLED STUDY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOOD REGURGITATION; GASTRITIS; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NAUSEA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; VOMITING;

ADULT; BODY MASS INDEX; DYSPEPSIA; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS;

EID: 65449172438     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215386     Document Type: Article

References (39)

1. Suzuki H, Hibi T, Marshall BJ: Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1-15.
2. Asaka M, Kato M, Sugiyama T, et al: Follow-up survey of a large-scale multicenter double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol 2003;38:339-347.
3. Miwa H, Sakaki N, Sugano K, et al: Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 2004;9:9-16.
4. MaColl K, Murray L, El-Omar E, et al: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869-1874.
5. Azuma T, Ito Y, Suto H, et al: The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan. Aliment Pha rmacol Ther 2001;15:805-811.
6. Suzuki H, Masaoka T, Sakai G, et al: Improvement of gastrointestinal quality of life (QOL) scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol 2005;20:1652-1660.
7. Suzuki H, Nishizawa T, Hibi T: Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol 2006;41:513-523.
8. Miwa H, Hirai S, Nagahara A, et al: Cure of H. pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. Aliment Pharmacol Ther 2000;14:317-324.
9. Froehlich F, Govers JJ, Wietlisbach V, et al: Helicobacter pylori eradication treatment does not benefit patients with non-ulcer dyspepsia. Am J Gastroenterol 2001;96:2329-2336.
10. Danesh J, Peto R: Risk factors for coronary heart disease a nd infection with Helicobacter pylori:meta-analysis of 18 studies. BMJ 1998;316:1130-1132.
11. Rosenstock SJ, Jorgensen T, Andersen LP, et al: Association of Helicobacter pylori infection with lifestyle, chronic disease, body indices, and age at menarche in Danish adults. Scand J Public Health 2000;28:32-40.
12. Azuma T, Suto H, Ito Y, et al: Eradication of Helicobacter pylori infection induces an increase in body mass index. Aliment Pharmacol Ther 2002;16(suppl 2):240-244.
13. Azuma T, Suto H, Ito Y, et al: Gastric leptin and Helicobacter pylori infection. Gut 2001;49:324-329.
14. Fur uta T, Shirai N, X iao F, et al: Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 2002;16:799-806.
15. Fujiwara Y, Higuchi K, Arafa UA, et al: Longterm effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer diseases. Hepatogastroenterology 2002;49:1298-1302.
16. Kamada T, Hata J, Kusunoki H, et al: Eradication of Helicobacter pylori increases the incidence of hyperlipidemia and obesity in peptic ulcer patients. Dig Liver Dis 2005;37:39-43.
17. Moldawer LL, Georgieff M, Lundholm K: Interleukin 1, tumor necrosis factor-alpha (cachectin) and the pathogenesis of cancer ca-chexia. Clin Physiol 1987;7:263-274.
18. Bendtzen K: Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett 1988;19:183-192.
19. Mori M, Yamaguchi K, Honda S, et al: Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 1991;51:6656-6659.
20. Milman N, Rosenstock S, Andersen L, et al: Serum ferritin, hemoglobin, Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology 1998;115:268-274.
21. Fischer RS, Parkman HP: Management of nonulcer dyspepsia. N Engl J Med 1998;339:1376-1381.
22. Samloff IM, Varis K, Ihamaki T, et al: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982;83:204-209.
23. Miki K, Ichinose M, Shimizu A, et al: Serum pepsinogen as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22: 133-141.
24. Suzuki H, Masaoka T, Hosoda H, et al: Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio-a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 20 04;51:1249-1254.
25. Kuwahara Y, Kono S, Eguchi H, et al: Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men. Scand J Gastroenterol 200 0;35:476-481.
26. Urita Y, Hike K, Torii N, et al: Serum pep-sinogen as a predictor of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 20 04;49:795-801.
27. Iijima K, Sekine H, Koike T, et al: Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and-positive Japanese subjects. J Gastroenterol 2005;40:938-944.
28. Labenz J, Malfertheiner P: Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor. Gut 1997;41:277-280.
29. Iijima K, Ohara S, Sekine H, et a l: Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20-26.
30. Iijima K, Ohara S, Sekine H, et al: Recovery of gastric acid secretion and mucosal atrophy after H. pylori eradication in severe atrophic gastritis. Gastroenterology 1998;114:A156.
31. Iijima K, Sekine H, Koike T, et al: Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther 2004;19:1181-1188.
32. Koike T, Ohara S, Sekine H, et al: Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 2001;15:813-820.
33. Beales I, Blaser ML, Srinivasan S, et al: Effect of Helicobacter pylori products and recombi-nant cytokines on gastrin release from cultured canine G cells. Gastroenterology 1997;11 3:15-24.
34. Miwa H, Nakajima K, Yamaguchi K, et al: Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther 2007;26:257-264.
35. Kojima M, Hosoda H, Date Y, et al: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402: 656-660.
36. Nwokolo CU, Freshwater DA, O'Hare P, et al: Plasma ghrelin following cure of Helicobacter pylori. Gut 20 03;52: 637- 640.
37. Suzuki H, Masaoka T, Hosoda H, et al: Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 2004;53:187-194.
38. Nishizawa T, Suzuki H, Nomoto Y, et al: Enhanced pla sma g hreli n levels i n patients with functional dyspepsia. Aliment Pharmacol Ther 2006;2 4(suppl 4):104-110.
39. Osawa H, Nakazato M, Date Y, et al: Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005;90:10-16.